Literature DB >> 15369450

Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction.

P de Cremoux1, I Bieche, C Tran-Perennou, S Vignaud, E Boudou, B Asselain, R Lidereau, H Magdelénat, V Becette, B Sigal-Zafrani, F Spyratos.   

Abstract

Quantitative reverse transcription-polymerase chain reaction (RT-PCR) used to detect minor changes in specific mRNA concentrations may be associated with poor reproducibility. Stringent quality control is therefore essential at each step of the protocol, including the PCR procedure. We performed inter-laboratory quality control of quantitative PCR between two independent laboratories, using in-house RT-PCR assays on a series of hormone-related target genes in a retrospective consecutive series of 79 breast tumors. Total RNA was reverse transcribed in a single center. Calibration curves were performed for five target genes (estrogen receptor (ER)alpha, ERbeta, progesterone receptor (PR), CYP19 (aromatase) and Ki 67) and for two reference genes (human acidic ribosomal phosphoprotein PO (RPLPO) and TATA box-binding protein (TBP)). Amplification efficiencies of the calibrator were determined for each run and used to calculate mRNA expression. Correlation coefficients were evaluated for each target and each reference gene. A good correlation was observed for all target and reference genes in both centers using their own protocols and kits (P < 0.0001). The correlation coefficients ranged from 0.90 to 0.98 for the various target genes in the two centers. A good correlation was observed between the level of expression of the ERalpha and the PR transcripts (P < 0.001). A weak inverse correlation was observed in both centers between ERalpha and ERbeta levels, but only when TBP was the reference gene. No other correlation was observed with other parameters. Real-time PCR assays allow convenient quantification of target mRNA transcripts and quantification of target-derived nucleic acids in clinical specimens. This study addresses the importance of inter-laboratory quality controls for the use of a panel of real-time PCR assays devoted to clinical samples and protocols and to ensure their appropriate accuracy. This can also facilitate exchanges and multicenter comparison of data.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15369450     DOI: 10.1677/erc.1.00808

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  13 in total

1.  Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer.

Authors:  Armelle Corpet; Leanne De Koning; Joern Toedling; Alexia Savignoni; Frédérique Berger; Charlène Lemaître; Roderick J O'Sullivan; Jan Karlseder; Emmanuel Barillot; Bernard Asselain; Xavier Sastre-Garau; Geneviève Almouzni
Journal:  EMBO J       Date:  2010-12-21       Impact factor: 11.598

2.  The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.

Authors:  Rocío Montes de Oca; Zachary A Gurard-Levin; Frédérique Berger; Haniya Rehman; Elise Martel; Armelle Corpet; Leanne de Koning; Isabelle Vassias; Laurence O W Wilson; Didier Meseure; Fabien Reyal; Alexia Savignoni; Bernard Asselain; Xavier Sastre-Garau; Geneviève Almouzni
Journal:  Mol Oncol       Date:  2014-11-20       Impact factor: 6.603

3.  A single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimens.

Authors:  Ayuko A Iverson; Cheryl Gillett; Paul Cane; Christopher D Santini; Thomas M Vess; Lauren Kam-Morgan; Alice Wang; Marcia Eisenberg; Charles M Rowland; Janice J Hessling; Samuel E Broder; John J Sninsky; Andrew Tutt; Steven Anderson; Sheng-Yung P Chang
Journal:  J Mol Diagn       Date:  2009-03       Impact factor: 5.568

4.  Assessment of transcriptional activity of Borrelia burgdorferi and host cytokine genes during early and late infection in a mouse model.

Authors:  Emir Hodzic; Sunlian Feng; Stephen W Barthold
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-09       Impact factor: 2.133

5.  Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.

Authors:  Ze-Yi Zheng; Meenakshi Anurag; Jonathan T Lei; Jin Cao; Purba Singh; Jianheng Peng; Hilda Kennedy; Nhu-Chau Nguyen; Yue Chen; Philip Lavere; Jing Li; Xin-Hui Du; Burcu Cakar; Wei Song; Beom-Jun Kim; Jiejun Shi; Sinem Seker; Doug W Chan; Guo-Qiang Zhao; Xi Chen; Kimberly C Banks; Richard B Lanman; Maryam Nemati Shafaee; Xiang H-F Zhang; Suhas Vasaikar; Bing Zhang; Susan G Hilsenbeck; Wei Li; Charles E Foulds; Matthew J Ellis; Eric C Chang
Journal:  Cancer Cell       Date:  2020-03-05       Impact factor: 31.743

6.  Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients.

Authors:  Patricia de Cremoux; Fabien Valet; David Gentien; Jacqueline Lehmann-Che; Véronique Scott; Carine Tran-Perennou; Catherine Barbaroux; Nicolas Servant; Sophie Vacher; Brigitte Sigal-Zafrani; Marie-Christine Mathieu; Philippe Bertheau; Jean-Marc Guinebretière; Bernard Asselain; Michel Marty; Frédérique Spyratos
Journal:  BMC Cancer       Date:  2011-06-01       Impact factor: 4.430

Review 7.  Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.

Authors:  Elisabeth Luporsi; Fabrice André; Frédérique Spyratos; Pierre-Marie Martin; Jocelyne Jacquemier; Frédérique Penault-Llorca; Nicole Tubiana-Mathieu; Brigitte Sigal-Zafrani; Laurent Arnould; Anne Gompel; Caroline Egele; Bruno Poulet; Krishna B Clough; Hubert Crouet; Alain Fourquet; Jean-Pierre Lefranc; Carole Mathelin; Nicolas Rouyer; Daniel Serin; Marc Spielmann; Margaret Haugh; Marie-Pierre Chenard; Etienne Brain; Patricia de Cremoux; Jean-Pierre Bellocq
Journal:  Breast Cancer Res Treat       Date:  2011-11-03       Impact factor: 4.872

8.  Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.

Authors:  Jérôme Toussaint; Anieta M Sieuwerts; Benjamin Haibe-Kains; Christine Desmedt; Ghizlane Rouas; Adrian L Harris; Denis Larsimont; Martine Piccart; John A Foekens; Virginie Durbecq; Christos Sotiriou
Journal:  BMC Genomics       Date:  2009-09-10       Impact factor: 3.969

9.  Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment.

Authors:  Marc A Bollet; Alexia Savignoni; Leanne De Koning; Carine Tran-Perennou; Catherine Barbaroux; Armelle Degeorges; Brigitte Sigal-Zafrani; Geneviève Almouzni; Paul Cottu; Rémy Salmon; Nicolas Servant; Alain Fourquet; Patricia de Cremoux
Journal:  Breast Cancer Res       Date:  2009-07-28       Impact factor: 6.466

10.  Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation.

Authors:  L de Plater; A Laugé; C Guyader; M-F Poupon; F Assayag; P de Cremoux; A Vincent-Salomon; D Stoppa-Lyonnet; B Sigal-Zafrani; J-J Fontaine; R Brough; C J Lord; A Ashworth; P Cottu; D Decaudin; E Marangoni
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.